Basic Information
ID: ALA3534566
Type: ADME
Description: Drug level assessed as recombinant human CYP3A5-mediated compound formation treated with lapatinib at 50 uM after 60 mins by GSH trapping assay in presence of NADPH
Format: BAO_0000357
Organism: Homo sapiens
Target: Cytochrome P450 3A5(ALA3019)
Document: ALA3526016
Drug level assessed as recombinant human CYP3A5-mediated compound formation treated with lapatinib at 50 uM after 60 mins by GSH trapping assay in presence of NADPH: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3534566
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 470.94 | 3.36 | 3.36 |